Navigation Links
AcelRx Pharmaceuticals Announces Closing Of Public Offering And Exercise Of Option To Purchase Additional Shares
Date:7/23/2013

REDWOOD CITY, Calif., July 23, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), today announced the closing of the public offering of 4,370,000 shares of common stock, including 570,000 shares of common stock which were issued pursuant to the exercise of the underwriters' option to purchase additional shares, at a price of $11.65 per share to the public. The total gross proceeds of this offering were approximately $50.9 million with estimated net proceeds to AcelRx of $47.9 million after deducting underwriting discounts and commissions and other estimated expenses payable by AcelRx.  

Jefferies LLC and Piper Jaffray & Co. acted as joint book-running managers for the offering, and Guggenheim Securities acted as co-manager for the offering.    

A shelf registration statement on Form S-3 relating to the public offering of the shares of common stock described above was filed with the Securities and Exchange Commission (the "SEC") and is effective.  A final prospectus supplement relating to the offering was filed with the SEC and is available on the SEC's web site at www.sec.gov. Copies of the final prospectus supplement may be obtained from the offices of Jefferies LLC, Equity Syndicate Prospectus Department, at 520 Madison Avenue, New York, New York, 10022, or by calling (877) 547-6340, or by emailing Prospectus_Department@Jefferies.com, or from Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402 or by calling (800)747-3924, or by emailing prospectus@pjc.com.

This press release shall not consti
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AcelRx Pharmaceuticals to Host Investor Day on June 27, 2013
2. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
3. AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
4. AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
5. AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting
6. Top-line Data Show AcelRx Pharmaceuticals ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
7. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results
8. AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013
9. AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients
10. AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. AcelRx Pharmaceuticals Provides Clinical Trial Updates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... -- Huntington Memorial Hospital is the first facility in ... replacement (TAVR), a minimally invasive replacement of heart valves. ... replace an aortic valve without a chest incision or ... The procedure is performed by a dedicated Huntington Hospital ... , MD, interventional cardiologist and Robbin Cohen , ...
(Date:3/26/2015)... S.C. , March 26, 2015 ... told by their existing PACS vendor their system ... (CMH) determined that they needed a better structured ... Hospital selected Avreo interWORKS due to its interface ... modern meaningful use standards through to the hospital,s ...
(Date:3/26/2015)... , March 26, 2015  Desert Valley Medical Center, ... times , is the first U.S. hospital to ... emergency department to help clinicians prevent hospital acquired pressure ... Victorville, Calif. , is a community hospital serving ... Using the Leaf Patient Monitor in the hospital,s emergency ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3
... within 5,minutes of dosing and is well-tolerated , ... Ltd,("Archimedes"), a European specialty pharmaceutical company, today,presented new ... Nasalfent(r),an innovative fentanyl citrate nasal spray aimed at ... cancer,pain. Data were presented at the 10th Congress ...
... dosed every two weeks achieved an SVR rate ... analysis), with,more favorable quality-of-life scores -, ROCKVILLE, Md., ... today announced the top-line final results of,a Phase ... with ribavirin in treatment-naive patients with,genotype 1 chronic ...
Cached Medicine Technology:Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 2Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 3Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 2Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 3Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 4Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 5Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 6Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 7Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 8
(Date:3/26/2015)... CA (PRWEB) March 26, 2015 The American ... will be on the topics of the DAOM Program as ... DAOM Program Overview Webinar will be hosted by Dr. Carla ... provide the next steps on how to prepare for the ... p.m. March 25, March 27, April 1 and April 3. ...
(Date:3/26/2015)... Doctors Scott Sullivan and Frank DellaCroce, Co-Founders of the ... the St. Charles Surgical Hospital (SCSH) in ... Surgical Oncologist Dr. William Karl Ordoyne has joined their ... surgical oncologist Alan Stolier, M.D., FACS and the team ... Sullivan, M.D., FACS; Chris Trahan, M.D., FACS; M. Whitten ...
(Date:3/26/2015)... PA (PRWEB) March 26, 2015 The ... a new team of nationally renowned scientists to focus ... B, a move that nearly triples its research capacity ... focusing solely on hepatitis B and liver cancer in ... Timothy Block, Jinhong Chang, Ju Tao Guo and Ying-Hsiu ...
(Date:3/26/2015)... 2015 Behavioral Research Group, LLC ... the release of BathroomMap® , a new bathroom ... to public restrooms for travelers, especially those with medical ... does not facilitate a paid, social or crowdsourced model, ... rate local establishments that have clean, available restrooms in ...
(Date:3/26/2015)... Visiting Nurse Association of Northern New Jersey ... Lighting the Way, Brightening the Day, on Friday, May ... in Morristown, NJ. , Guests will enjoy an ... Clemente, delightful cuisine, an extensive silent auction and heart-warming ... prestigious awards will be presented to this year’s honorees. ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming Webinars 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 2Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 4Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2
... China Yingxia,International, Inc. (OTC Bulletin Board: CYXI) ... the nutraceutical industry engaged in the,development, manufacture ... and personal care products in the People,s ... has retained CCG Elite to design,and execute ...
... About the Importance of Regular Eye Care, ... the nationwide launch of its "See America" contest, ... preventive eye exams to promote,overall vision health. The ... sight will award the grand prize winner,with the ...
... Clinicogenomic Model Has Highest Prediction Accuracy for Lung ... an emerging,leader in the field of molecular diagnostics ... model for lung cancer diagnosis in the,inaugural edition ... American Association for Cancer Research (AACR), which is ...
... to expand the $200 million surgical ... Group, WALTHAM, Mass., April 14, 2008 According ... 2008 report,the surgical navigation market was worth almost $200 ... five years. This growth will be partly,facilitated by soft ...
... BioElectronics President, CEO, and Chairman Issues Shareholder ... Andrew Whelan,President, CEO and Chairman of BioElectronics, ... FDA-cleared, drug-free anti-inflammatory patch,with an embedded battery ... relieve pain and speed healing, today issued ...
... 14 The rating,agency Standard & Poor,s has raised ... stable". This means that Gerresheimer is now only one,step ... justification for the upgrade, Standard & Poor,s emphasises the,positive ... EBITDA.,Gerresheimer, it says, will be able to sustain this ...
Cached Medicine News:Health News:China Yingxia International, Inc. Retains CCG Elite 2Health News:China Yingxia International, Inc. Retains CCG Elite 3Health News:Prevent Blindness America Invites Consumers to 'See America' Through Nationwide Contest 2Health News:Prevent Blindness America Invites Consumers to 'See America' Through Nationwide Contest 3Health News:Prevent Blindness America Invites Consumers to 'See America' Through Nationwide Contest 4Health News:Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features 2Health News:Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features 3Health News:New Technology Promises Safer Organ Transplants and Soft Tissue Surgeries 2Health News:New Technology Promises Safer Organ Transplants and Soft Tissue Surgeries 3Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 2Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 3Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 4Health News:Standard & Poor's Raises Gerresheimer Rating to BB+ 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: